Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stout

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Biochemistry and Molecular Biology|March 31, 2007
Suppression subtractive hybridization identifies novel transcripts in regenerating Hydra littoralisThomas Stout, Trevor McFarland, Binoy Appukuttan
Urology|January 7, 2023
EDITORIAL COMMENTThomas Stout, Chad R Tracy, Ryan L Steinberg
Case Reports in Orthopedics|September 9, 2014
Successful nonoperative treatment of isolated popliteus tendon avulsion fractures in two adolescentsScott D McKay, Andrew Holt, Thomas Stout, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinibJuliann Chmielecki, M Catherine Pietanza, Dana Aftab, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2014
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβEllen Kick, Richard Martin, Yinong Xie, et al.
Journal of Medicinal Chemistry|May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitorsJames W Leahy, Chris A Buhr, Henry W B Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2012
SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitorsTimothy Forsyth, Patrick C Kearney, Byung Gyu Kim, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Biochemistry and Molecular Biology|March 31, 2007
Suppression subtractive hybridization identifies novel transcripts in regenerating Hydra littoralisThomas Stout, Trevor McFarland, Binoy Appukuttan
Urology|January 7, 2023
EDITORIAL COMMENTThomas Stout, Chad R Tracy, Ryan L Steinberg
Case Reports in Orthopedics|September 9, 2014
Successful nonoperative treatment of isolated popliteus tendon avulsion fractures in two adolescentsScott D McKay, Andrew Holt, Thomas Stout, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinibJuliann Chmielecki, M Catherine Pietanza, Dana Aftab, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2014
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβEllen Kick, Richard Martin, Yinong Xie, et al.
Journal of Medicinal Chemistry|May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitorsJames W Leahy, Chris A Buhr, Henry W B Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2012
SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitorsTimothy Forsyth, Patrick C Kearney, Byung Gyu Kim, et al.
Pageof 1